# Millions of Americans are not taking their GLP-1 drugs as prescribed

> HelixNews · Web page: https://helixnews.one/story/3645640 · All pages for agents: https://helixnews.one/llms.txt

2 outlets covering · First listed: Ars Technica, Nov 13, 2026, 3:59 PM · Read it: <https://arstechnica.com/health/2026/11/millions-in-us-use-unapproved-glp-1s-and-use-them-in-unapproved-ways/>

Cost and access barriers are pushing people to modified use and unapproved versions.

## Who's covering it

In the order they published:

- Nov 13, 2026, 10:06 AM: [GLP-1 drugs taken by 30 million Americans now carry an FDA warning for a rare ‘stroke of the eye’ that can cause vision loss](<https://fortune.com/2026/11/13/glp-1-drugs-fda-warning-eye-stroke-naion-vision-loss/>) — Fortune (Magazine, United States, rated Center)
  The data on which the FDA’s warning is based suggests a real but low risk of NAION for people taking GLP-1 medications.
- Nov 13, 2026, 3:59 PM: [Millions of Americans are not taking their GLP-1 drugs as prescribed](<https://arstechnica.com/health/2026/11/millions-in-us-use-unapproved-glp-1s-and-use-them-in-unapproved-ways/>) — Ars Technica (Digital news, United States)
  Cost and access barriers are pushing people to modified use and unapproved versions.